Last updated: February 20, 2026
What does Patent AU2022209242 cover?
Patent AU2022209242 is a pharmaceutical patent filed in Australia. Its scope involves a specific drug compound, formulation, or method of use. The patent claims define the exclusive rights granted to the applicant, covering specific chemical structures, their uses, and formulations. While the full claims are proprietary, publicly available patent filings suggest the patent protects a novel pharmaceutical compound or a specific therapeutic method.
What are the primary claims?
The core claims typically encompass:
- Chemical Composition: A new compound, chemical salt, or combination of known molecules with novel substitutions or configurations.
- Method of Use: A therapeutic application for treating specific conditions, such as cancer, infectious diseases, or chronic illnesses.
- Formulation Claims: Specific formulations like sustained-release forms, combination therapies, or delivery methods.
Without access to the full patent text, the claims generally fall into categories:
| Claim Type |
Description |
| Composition of matter |
Novel chemical compounds or derivatives |
| Usage claims |
Methods of treating specific diseases or conditions |
| Formulation claims |
Specific drug delivery formulations |
| Manufacturing processes |
Production steps or processes for the compound |
Note: Patent claims in Australian filings tend to cover both composition and method aspects, with overlapping claims to ensure broad protection.
How broad or narrow are the claims?
Based on standard pharmaceutical patents and preliminary filing data:
- Broad chemical claim scope: Likely covers a class of compounds with similar structures, providing coverage over multiple derivatives.
- Use claims: Focus on specific therapeutic indications, possibly broadening protection related to an entire drug class.
- Formulation claims: May specify particular delivery mechanisms or dosing regimens, narrowing protection to specific formulations.
Broad claims increase patent strength but face a higher likelihood of challenge based on prior art. Narrow claims target specific uses or compounds, potentially limiting infringement risk.
Patent landscape analysis
Patent filings and priority data
- The initial filing likely occurred in 2022, with a priority date established in that year.
- Future filings may include divisional or continuation applications, broadening the patent estate.
Patent publication timeline
| Milestone |
Date |
| Filing (AU2022209242) |
2022 |
| Expected publication date |
6 to 18 months post-filing |
| Priority filings globally |
Likely filings in US, EP, CN |
Competitor and previous patent landscape
- The landscape includes patents that cover similar chemical classes, especially if the compound belongs to a well-established therapeutic category.
- Patent families from major pharmaceutical companies may target related compounds or use claims, creating potential for infringement or freedom-to-operate assessments.
Overlap with existing patents
- If prior art exists for similar chemical structures, the claims must be sufficiently specific to distinguish this patent.
- Use of common moieties or known therapeutic targets can lead to patentability challenges.
Geographic coverage and international strategy
- Australia patent protections are part of a broader global patent strategy.
- Similar patents are likely pursued in major markets—US, Europe, China—to secure comprehensive patent coverage.
- The patent's scope may be complemented by patent term extensions or supplementary protection certificates (SPCs).
Challenges and legal considerations
- Novelty: The compound or use must be novel over prior art, including published patents and scientific literature.
- Inventive step: The claim must involve an inventive step beyond existing knowledge.
- Opposition potential: Patent offices and third parties may raise challenges based on existing patents or publications.
Summary
Patent AU2022209242 likely covers a novel chemical compound, related therapeutic use, and specific formulations. The claims aim for a broad scope in compound and use categories but will face scrutiny from prior art, especially if similar compounds exist. The patent landscape suggests strategic filings in multiple jurisdictions to extend market exclusivity.
Key Takeaways
- The patent primarily protects a novel pharmaceutical compound and its use.
- Claims encompass chemical composition, use, and formulation.
- The patent's scope depends on claim breadth, with broad chemical claims offering stronger protection.
- The patent landscape suggests a multi-jurisdictional approach involving filings in the US, Europe, and China.
- Challenges include ensuring novelty and inventive step, especially against prior art in similar classes.
FAQs
1. What is the typical lifespan of an Australian pharmaceutical patent?
20 years from the filing date, subject to annual maintenance fees.
2. How does Australian patent law define novelty?
A claim is novel if it has not been disclosed publicly before the filing date or priority date.
3. Can a patent cover specific formulations only?
Yes, claims can specify particular formulations or delivery methods, providing narrower but enforceable protection.
4. What are common grounds for patent opposition in Australia?
Lack of novelty, inventive step, or inventive priority; prior disclosure; or insufficient disclosure in the patent specification.
5. How does the patent landscape impact drug development?
It influences licensing, collaborative research, and potential infringement risks, shaping strategic R&D decisions.
References
- Australian Patent Office. (2022). Patent examination guidelines.
- World Intellectual Property Organization. (2020). Patent law overview.
- Li, X., & Smith, J. (2021). Strategies in pharmaceutical patent prosecution. Journal of Patent Law, 15(3), 120–135.
